Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Silverceuticals Inc. has 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed between 2 distinct examiners. JOYNER, KEVIN is identified as the busiest examiner, with 1 pending office action currently under review.
The portfolio's activity is contained within 1 distinct art unit. Although there are 2 distinct examiners, the fact that they both operate within the same art unit suggests a focused technological scope for the 2 pending office actions. JOYNER, KEVIN handles 1 of these actions, representing a portion of the company's current pending workload. This arrangement provides a comparative view of how different examiners within the same Biotechnology & Pharmaceuticals art unit handle the company's applications. Practitioners can leverage this to see if prosecution hurdles are consistent across the 1 distinct art unit or if they vary by examiner. The presence of 2 distinct examiners for only 2 pending actions ensures that no single individual controls the entire portfolio.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| JOYNER, KEVIN | 1 | 68.3% | +23.6% |
| HELM, CARALYNNE E | 1 | 28.9% | +49.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18755456 | METHODS AND FOODS INCLUDING SILVER COMPOUNDS TO PROTECT ANIMALS FROM PATHOGENIC BACTERIA AND DISEASE | HELM, CARALYNNE E | 36d overdue |
| 18726344 | USING SILVER COMPOSITIONS TO DISINFECT SURFACES | JOYNER, KEVIN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18755456 | METHODS AND FOODS INCLUDING SILVER COMPOUNDS TO PROTECT ANIMALS FROM PATHOGENIC BACTERIA AND DISEASE | HELM, CARALYNNE E | 36d overdue |
| 18726344 | USING SILVER COMPOSITIONS TO DISINFECT SURFACES | JOYNER, KEVIN | — |
| Art Unit | Apps |
|---|---|
| 1615 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18726344 | USING SILVER COMPOSITIONS TO DISINFECT SURFACES | JOYNER, KEVIN | — | §102§103 | Non-Final OA | — | Pending | Jul 02, 2024 |
| 18755456 | METHODS AND FOODS INCLUDING SILVER COMPOUNDS TO PROTECT ANIMALS FROM PATHOGENIC BACTERIA AND DISEASE | HELM, CARALYNNE E | 1615 | §102§103§112 | Non-Final OA | 36d overdue | Pending | Jun 26, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial